GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » ROE % Adjusted to Book Value

Curocell (XKRX:372320) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell ROE % Adjusted to Book Value?

Curocell's ROE % for the quarter that ended in Jun. 2023 was 0.00%. Curocell's PB Ratio for the quarter that ended in Jun. 2023 was N/A. Curocell's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was N/A.

Curocell ROE % Adjusted to Book Value Historical Data

The historical data trend for Curocell's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell ROE % Adjusted to Book Value Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - - -62.34

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value - - - -7.97

Competitive Comparison of Curocell's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Curocell's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curocell's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Curocell's ROE % Adjusted to Book Value falls into.


Curocell ROE % Adjusted to Book Value Calculation

Curocell's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-514.27% / 8.25
=-62.34%

Curocell's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curocell ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Curocell's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines